Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech's Board of Directors met on June 11, 2025 and approved two new appointments. Ms. Priya Rajender Goda (DIN: 07402785) was appointed as Additional Independent Director, and Mr. Satyanarayana Vedula (DIN: 09070986) was appointed as Additional Non-Executive Non-Independent Director, both for a 5-year term. Both appointments are subject to shareholder approval via postal ballot. The Board also reconstituted its Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee, effective June 12, 2025, with Ms. Goda chairing the Audit Committee and Stakeholders Relationship Committee. Ms. Goda has an MBA and brings experience from Dell Financial Services and CSR consulting, while Mr. Vedula is a Chartered Accountant currently serving as Vice Chairman and Executive Director at Virinchi Limited, with over 23 years at Tech Mahindra in executive leadership roles.
This is a routine board expansion that strengthens corporate governance by adding an Independent Director who will chair key committees like Audit and Stakeholders Relations. For shareholders, the postal ballot offers a chance to vote on these appointments, and the new directors bring diverse expertise in finance, consulting, and technology to support the company's growth.